Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Two studies recently published on the Control-IQ and MiniMed 780G systems show that closed-loop automated insulin delivery significantly improves Time in Range.
Recent studies published in Diabetes Technology & Therapeutics on Tandem’s Control-IQ and Medtronic’s MiniMed 780G showed promising results in automated insulin delivery (AID). Both real-world studies provide further evidence that AID systems have the ability to greatly improve diabetes management and Time in Range (TIR).
diatribe.org
Recent studies published in Diabetes Technology & Therapeutics on Tandem’s Control-IQ and Medtronic’s MiniMed 780G showed promising results in automated insulin delivery (AID). Both real-world studies provide further evidence that AID systems have the ability to greatly improve diabetes management and Time in Range (TIR).
Automated Insulin Delivery in the Real World – Exciting New Results
Two studies recently published on the Control-IQ and MiniMed 780G systems show that closed-loop automated insulin delivery significantly improves Time in Range.